Low-grade endometrial adenocarcinoma: A diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics

Advances in Anatomic Pathology

Volumn 16, Issue 1, 2009, Pages 1-22

  McKenney, Jesse K ^a   Longacre, Teri A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Atypical endometrial hyperplasia; Atypical polypoid adenomyoma; Endometrial adenocarcinoma; Endometrial hyperplasia; Endometrial metaplasia; Endometrioid; Endometrium; Hyperplasia; Well differentiated endometrial adenocarcinoma

Indexed keywords

GESTAGEN;

ADENOMYOMA; ADENOSARCOMA; ALGORITHM; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CLEAR CELL CARCINOMA; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; PATHOLOGIST; PRECANCER; PRIORITY JOURNAL; REVIEW; SEX CORD TUMOR; SQUAMOUS CELL METAPLASIA; SURGEON; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA; UTERUS TUMOR; ADENOCARCINOMA; CELL DIVISION; ENDOMETRIUM; ENDOMETRIUM TUMOR; FEMALE; HYPERPLASIA; KINETICS; METAPLASIA; PATHOLOGY; RISK ASSESSMENT; UTERUS DISEASE;

ADENOCARCINOMA; ALGORITHMS; CELL DIVISION; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; HYPERPLASIA; KINETICS; METAPLASIA; NEOPLASM INVASIVENESS; RISK ASSESSMENT; UTERINE DISEASES;

EID: 59849106858     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3181919e15     Document Type: Review

References (61)

1. Soslow RA. Problems with the current diagnostic approach to complex atypical endometrial hyperplasia. Cancer. 2006;106: 729-731.
2. Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106:812-819. (Pubitemid 43238448)
3. Zaino RJ, Kauderer J, Trimble CL, et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106:804-811. (Pubitemid 43238447)
4. Soothill PW, Alcock CJ, MacKenzie IZ. Discrepancy between curettage and hysterectomy histology in patients with stage 1 uterine malignancy. Br J Obstet Gynaecol. 1989;96:478-481.
5. Mutter GL. Histopathology of genetically defined endometrial precancers. Int J Gynecol Pathol. 2000;19:301-309.
6. Mutter GL. Diagnosis of premalignant endometrial disease. J Clin Pathol. 2002;55:326-331.
7. Mutter GL, Baak JP, Crum CP, et al. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol. 2000;190:462-469.
8. Mutter GL, Ince TA, Baak JP, et al. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res. 2001;61:4311-4314.
9. Kurman R, Norris H. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer. 1982;49:2547-2559.
10. Longacre TA, Chung MH, Jensen DN, et al. Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion. Am J Surg Pathol. 1995;19: 371-406.
11. Hendrickson MR, Longacre TA, Kempson RL. The uterine corpus. In: Sternberg S, Mills S, eds. Diagnostic Surgical Pathology. New York: Raven Press; 2004:2203-2305.
12. Zaman SS, Mazur MT. Endometrial papillary syncytial change. A nonspecific alteration associated with active breakdown. Am J Clin Pathol. 1993;99:741-745.
13. Lehman MB, Hart WR. Simple and complex hyperplastic papillary proliferations of the endometrium: a clinicopathologic study of nine cases of apparently localized papillary lesions with fibrovascular stromal cores and epithelial metaplasia. Am J Surg Pathol. 2001;25:1347-1354.
14. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14: 931-968. (Pubitemid 14209714)
15. Longacre TA, Hendrickson MR. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion. Am J Surg Pathol. 1999;23:69-78.
16. Hendrickson M, Kempson R. Endometrial epithelial metaplasias: proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol. 1980;4:525-542. (Pubitemid 11104410)
17. Kurman R, Kaminski P, Norris H. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer. 1985;56:403-412.
18. Huang S, Amparo E, Fu Y. Endometrial hyperplasia: Histologic classification and behavior. Surg Pathol. 1988;1: 215-229.
19. Silverberg SG, Kurman RJ, Nogales F, et al. Tumours of the Uterine Corpus. In: Tavassoli FA, Devilee P, eds. WHO Classification of Tumours: Tumours of the Breast and Female Genital Organs. Lyon, France: IARC; 2003.
20. Kendall BS, Ronnett BM, Isacson C, et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol. 1998;22: 1012-1019. (Pubitemid 28364502)
21. Allison KH, Reed SD, Voigt LF, et al. Diagnosing endometrial hyperplasia: why is it so difficult to agree?. Am J Surg Pathol. 2008;32:691-698.
22. Lacey JV, Mutter GL, Nucci MR, et al. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer. 2008;113:2073-2081.
23. Nucci MR, Prasad CJ, Crum CP, et al. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance. Mod Pathol. 1999;12: 1137-1142.
24. Vang R, Tavassoli FA. Proliferative mucinous lesions of the endometrium: analysis of existing criteria for diagnosing carcinoma in biopsies and curettings. Int J Surg Pathol. 2003;11:261-270. (Pubitemid 37433285)
25. Young R, Scully R. Uterine carcinomas simulating microglandular hyperplasia. A report of six cases. Am J Surg Pathol. 1992;16:1092-1097.
26. Young RH, Scully RE. Atypical forms of microglandular hyperplasia of the cervix simulating carcinoma. A report of five cases and review of the literature. Am J Surg Pathol. 1989;13:50-56.
27. Mazur MT, Kurman RJ. Diagnosis of Endometrial Biopsies and Curettings: a Practical Approach. New York: Springer-Verlag; 2004.
28. Shah SS, Mazur MT. Endometrial eosinophilic syncytial change related to breakdown: immunohistochemical evidence suggests a regressive process. Int J Gynecol Pathol. 2008;27: 534-538.
29. Jacques SM, Qureshi F, Lawrence WD. Surface epithelial changes in endometrial adenocarcinoma: diagnostic pitfalls in curettage specimens. Int J Gynecol Pathol. 1995;14: 191-197.
30. Arias-Stella J. The Arias-Stella reaction: facts and fancies four decades after. Adv Anat Pathol. 2002;9:12-23.
31. Zaino RJ. The fruits of our labors: distinguishing endometrial from endocervical adenocarcinoma. Int J Gynecol Pathol. 2002;21:1-3.
32. Alkushi A, Irving J, Hsu F, et al. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch. 2003;442:271-277. (Pubitemid 36399222)
33. Castrillon DH, Lee KR, Nucci MR. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Int J Gynecol Pathol. 2002;21:4-10. (Pubitemid 34008346)
34. Kamoi S, AlJuboury MI, Akin MR, et al. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint. Int J Gynecol Pathol. 2002;21:217-223. (Pubitemid 34680337)
35. McCluggage WG, Sumathi VP, McBride HA, et al. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol. 2002;21:11-15.
36. Ansari-Lari MA, Staebler A, Zaino RJ, et al. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol. 2004;28: 160-167. (Pubitemid 38124723)
37. Staebler A, Sherman ME, Zaino RJ, et al. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol. 2002;26: 998-1006. (Pubitemid 34810560)
38. Kong CS, Gilks CB, Longacre TA. Immunohistochemical stain for p16 can be misleading in disitnguishing endometrial from endocervical adenocarcinoma in small tissue samples. Mod Pathol. 2005;18:189A.
39. Longacre TA, Chung MH, Rouse RV, et al. Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus. A clinicopathologic study of 55 cases. Am J Surg Pathol. 1996;20:1-20.
40. Mazur MT. Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol. 1981;5:473-482.
41. Young R, Treger T, Scully R. Atypical polypoid adenomyoma of the uterus. A report of 27 cases. Am J Clin Pathol. 1986;86: 139-145. (Pubitemid 16072289)
42. Lee KR. Atypical polypoid adenomyoma of the endometrium associated with adenomyomatosis and adenocarcinoma. Gynecol Oncol. 1993;51:416-418. (Pubitemid 2033994)
43. Mittal KR, Peng XC, Wallach RC, et al. Coexistent atypical polypoid adenomyoma and endometrial adenocarcinoma. Hum Pathol. 1995;26:574-576.
44. Sugiyama T, Ohta S, Nishida T, et al. Two cases of endometrial adenocarcinoma arising from atypical polypoid adenomyoma. Gynecol Oncol. 1998;71:141-144. (Pubitemid 28492410)
45. Gilks CB, Young RH, Clement PB, et al. Adenomyomas of the uterine cervix of endocervical type: a report of ten cases of a benign cervical tumor that may be confused with adenoma malignum [corrected]. Mod Pathol. 1996;9:220-224.
46. Clement P, Scully R. Mullerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of mullerian mixed tumor. Cancer. 1974;34:1138-1149.
47. Clement P, Scully R. Mullerian adenosarcomas of the uterus with sex cord-like elements. A clinicopathologic analysis of eight cases. Am J Clin Pathol. 1989;91:664-672. (Pubitemid 19153184)
48. Clement P, Scully R. Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol. 1990;21:363-381. (Pubitemid 20141021)
49. Clement P, Scully R. Endometrial stromal sarcomas of the uterus with extensive endometrioid glandular differentiateion: a report of three cases that caused problems in differential diagnosis. Int J Gynecol Path. 1992;11:163-173.
50. Clement P, Scully R. Uterine tumors resembling ovarian sexcord tumors. A clinicopathologic analysis of fourteen cases. Am J Clin Pathol. 1976;66:512-525.
51. Baker RJ, Hildebrandt RH, Rouse RV, et al. Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements. Hum Pathol. 1999;30:671-679.
52. Murray SK, Clement PB, Young RH. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms. Am J Surg Pathol. 2005;29:157-166.
53. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol. 2002;9:145-184.
54. Silva EG, Young RH. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type. Am J Surg Pathol. 2007;31:1203-1208.
55. Murray SK, Young RH, Scully RE. Uterine endometrioid carcinoma with small nonvillous papillae: an analysis of 26 cases of a favorable-prognosis tumor to be distinguished from serous carcinoma. Int J Surg Pathol. 2000;8:279-289.
56. Darvishian F, Hummer AJ, Thaler HT, et al. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases. Am J Surg Pathol. 2004;28:1568-1578. (Pubitemid 39564961)
57. Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol. 1995;26:1268-1274.
58. Alkushi A, Lim P, Coldman A, et al. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level. Int J Gynecol Pathol. 2004;23: 129-137. (Pubitemid 38391772)
59. Silva EG, Deavers MT, Bodurka DC, et al. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol. 2006;25: 52-58.
60. Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol. 1997;90: 434-440.
61. Alkushi A, Abdul-Rahman ZH, Lim P, et al. Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems. Am J Surg Pathol. 2005;29:295-304. (Pubitemid 40321964)